From the Institute of Vision Research (YWJ, EKK, HKL, KYS, TK) and Corneal Dystrophy Research Institute (YWJ, EKK, HKL, KYS, TK), Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea; Hankuk Academy of Foreign Studies, Yongin, South Korea (MK); Eyereum Eye Clinic, Seoul, South Korea (DSYK, JYC); London Vision Clinic, London, United Kingdom (DZR, TJA); the Department of Ophthalmology, Columbia University Medical Center, New York (DZR); Centre Hospitalier National d'Ophtalmologie, Paris, France (DZR); and Biomedical Science Research Institute, University of Ulster, Coleraine, Northern Ireland (DZR, TJA).
Dr. Reinstein is a consultant for Carl Zeiss Meditec (Carl Zeiss Meditec AG, Jena, Germany) and has a proprietary interest in the Artemis technology (ArcScan, Inc., Golden, Colorado) through patents administered by the Center for Technology Licensing at Cornell University (CTL), Ithaca, New York. The remaining authors have no proprietary or financial interest in the materials presented herein.
Supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2016R1A2B4009626).
Study concept and design (YWJ, DSYK, KYS, TK); data collection (YWJ, DSYK, JYC, HKL); analysis and interpretation of data (YWJ, MK, DZR, TJA, EKK, TK); writing the manuscript (YWJ, DZR, TJA, TK); critical revision of the manuscript (YWJ, MK, DSYK, JYC, EKK, HKL, KYS, TK); administrative, technical, or material support (MK, TK); supervision (DSYK, HKL, TK)
Correspondence: Tae-im Kim, MD, PhD, Department of Ophthalmology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea. E-mail: